Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.

Cytotherapy · 2017 · PMC5571439 · PMID 28673774

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

GMP-grade TexMACS culture medium demonstrated a consistently higher conversion rate to macrophages compared with AIM-V, although this did not reach statistical significance ( Figure 1D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.